NasdaqGS:OMCLMedical Equipment
Omnicell (OMCL) Margin Squeeze To 0.2% Net Profit Tests Bullish Recovery Narratives
Omnicell (OMCL) has wrapped up FY 2025 with fourth quarter revenue of US$314 million and a basic EPS loss of US$0.05, alongside trailing twelve month EPS of US$0.04 that points to only a slim profit over the year. The company has seen quarterly revenue move from US$283 million in Q3 2024 to US$314 million in Q4 2025, while basic EPS shifted from US$0.19 in Q3 2024 to a loss of US$0.05 in the latest quarter, leaving margins looking tight and keeping the focus firmly on how sustainably...